Skip to main content

Table 1 Correlation between miR-501 expression and EC clinicopathological parameters

From: MiR-501 promotes tumor proliferation and metastasis by targeting HOXD10 in endometrial cancer

Parameters n miR-501 level p value
Low (n = 332) High (n = 206)
Age
 < 55 97 61 36 0.807
 ≥ 55 437 269 168
Peritoneal washing
 Negative 344 215 129 0.681
 Positive 57 34 23
Tumor status
 With tumor 77 52 25 0.688
 Tumor free 422 275 147
Lymph nodes (pelvic)
 Negative 339 213 126 0.018*
 Positive 73 35 38
Lymph nodes (aortic)
 Negative 263 160 103 0.119
 Positive 36 17 19
Stage
 I 338 202 136 0.200
 II–IV 199 130 69
Recurrence
 No 415 279 136 0.842
 Yes 76 46 30
  1. The data was from TCGA. The follow-up data of some patients are not complete, so the case number of some groups is smaller than the total, but there is no difference between the expression level of miR-501 in the omitted individuals compared with the listed ones
  2. *p < 0.05